Emerging Technologies and Computation Methods for Precision Medicine in Cancer—Ready for Use in Clinics?
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: closed (30 September 2021) | Viewed by 60934
Special Issue Editor
Special Issue Information
Dear Colleagues,
The theme is on clinical cancer genomics. The advent of cancer genomics technologies is providing increasingly more hope to improve cancer patient outcomes and the potential to reduce healthcare costs and adverse drug reactions. The role of biomarkers in cancer clinical trials has significantly increased in recent years, and availability and decreasing costs of high-throughput technologies has vastly increased the amount of molecular data derived from biospecimens collected in trials. In this Special Issue, we invite cancer researchers to submit original research articles, reviews or short communications that apply or develop emerging genomic technologies and computational methods for biomarker research that can be applied in clinical studies, and translational studies whose results are making real impact for clinical practice in cancer.
Dr. Maggie Chon U Cheang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.